Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Vicarious Surgical ( (RBOT) ) has provided an announcement.
On March 3, 2026, the New York Stock Exchange moved to suspend and delist Vicarious Surgical’s common stock after the company’s market capitalization fell below the exchange’s $15 million continued listing threshold, and Vicarious Surgical chose not to appeal; its shares began trading the next day on the OTCID market under the symbol RBOT, and the company has applied to move up to the OTCQB tier, though trading liquidity and ongoing quotations remain uncertain for investors. In financial results reported on March 9, 2026 for the quarter and year ended December 31, 2025, Vicarious Surgical posted narrower GAAP net losses year over year, driven by sharp reductions in operating, R&D, G&A, and sales and marketing expenses, ended 2025 with $9.8 million in cash and investments after a $45.1 million annual cash burn below prior guidance, and provided updated 2026 cash burn guidance of about $19 million, underscoring an aggressive cost-control push as it navigates life on the over-the-counter market.
The most recent analyst rating on (RBOT) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on Vicarious Surgical stock, see the RBOT Stock Forecast page.
Spark’s Take on RBOT Stock
According to Spark, TipRanks’ AI Analyst, RBOT is a Neutral.
The score is held down primarily by very weak financial performance (no revenue, large ongoing losses, heavy cash burn, and sharply reduced equity). Technicals also remain unfavorable with a clear longer-term downtrend and negative MACD. Offsetting factors include cost-cutting progress and improved cash-burn guidance plus financing actions, but these are not yet enough to outweigh the current funding and execution risk.
To see Spark’s full report on RBOT stock, click here.
More about Vicarious Surgical
Vicarious Surgical Inc. is a Waltham, Massachusetts-based next-generation surgical robotics company developing proprietary human-like robots designed to virtually transport surgeons inside the patient for minimally invasive procedures. Founded in 2014, it targets improved surgical efficiency, better patient outcomes and lower healthcare costs, and is backed by prominent technology-focused investors.
Average Trading Volume: 128,358
Technical Sentiment Signal: Sell
Current Market Cap: $1.92M
See more data about RBOT stock on TipRanks’ Stock Analysis page.